.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Smoking cessation presents unique challenges for marginalized groups who often lack access to tailored support. Consequently, a recent pilot study evaluated the EQQUAL program as a specialized SGM smoking cessation intervention. Specifically, this avatar-led digital health program utilizes Acceptance and Commitment Therapy (ACT) to help sexual and gender minority (SGM) young adults quit smoking.
Researchers recruited 124 participants aged 18 to 30 for this randomized controlled pilot trial. The team divided the cohort into two groups to compare EQQUAL with the standard Smokefree.gov program. Both interventions provided users with a web application and integrated text messaging services. After three months, the team assessed smoking abstinence through biochemical verification.
Results indicated that EQQUAL users experienced significantly higher rates of biochemically-verified abstinence. Specifically, 11.1% of the EQQUAL arm remained abstinent compared to only 4.9% in the control group. Moreover, participants reported higher overall satisfaction scores and usability ratings with the tailored digital interface. However, the study found that users only completed an average of 1.4 out of 6 digital sessions.
Furthermore, the theory-based change processes did not show robust differences between the two study arms. This suggests that while the tailored content improves immediate abstinence, the mechanism of change requires further investigation. Therefore, clinicians suggest that increasing user engagement might further improve these promising cessation outcomes. This specialized SGM smoking cessation intervention represents a vital step toward reducing health disparities in tobacco use.
Culturally-tailored digital tools offer a scalable solution for high-risk populations. Clinicians should consider such tools to support diverse patient populations effectively, especially those who may avoid traditional healthcare settings due to stigma. While initial results are positive, practitioners should emphasize the importance of completing all digital sessions to maximize the program's benefits.
The EQQUAL program is specifically tailored for sexual and gender minority young adults. It uses an avatar-led interface and Acceptance and Commitment Therapy (ACT) to address the unique psychosocial stressors and barriers this population faces when quitting smoking.
In the pilot trial, the EQQUAL group achieved a biochemically-verified abstinence rate of 11.1%. In contrast, the control group using the Smokefree.gov program achieved a rate of only 4.9%.
Despite higher satisfaction, user engagement remained low, with participants completing an average of only 1.4 out of 6 sessions. Researchers believe that increasing this engagement is key to further improving cessation outcomes.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized pilot trial evaluates EQQUAL, a digital health tool for SGM young adult smoking cessation, showing promising results over standard programs....
2 months ago
A SELECT trial post hoc analysis shows semaglutide 2.4 mg attenuates plasma proteomic signatures predicting 5- and 20-year dementia risk in non-diabetic older adults with overweight/obesity and cardiovascular disease, reducing odds of higher risk classification by 36%.
Today
A photovoice study in Elmhurst, Queens explores how low-income immigrant pregnant women express maternal resilience through nature, family bonds, community resources, and psychological reframing, providing vital insights for strengths-based prenatal care.
Today
A 57-year-old woman presented with severe dyspnea caused by a giant left atrial myxoma prolapsing into the mitral valve, creating functional mitral stenosis and pulmonary hypertension. She underwent successful minimally invasive thoracoscopic resection with complete symptom resolution and normalized pressures.
Today
A retrospective cohort study evaluated an extended medial approach with medial femoral epicondyle osteotomy for severe medial tibial plateau fractures, demonstrating comparable radiographic and functional outcomes to standard approaches.
Today
A study demonstrates that gomisin N (25 µM) protects MIN6 pancreatic beta-cells by alleviating endoplasmic reticulum and oxidative stress induced by CPA. By reducing ROS levels and promoting correct proinsulin folding, gomisin N restores insulin secretion and beta-cell viability in diabetes models.
Today
